Let's consider one company in each category. The one that could benefit from Anthropic's IPO is Broadcom ( AVGO -5.48%), and ...

Lilly is the maker of tirzepatide, a drug sold under the name Mounjaro for type 2 diabetes and as Zepbound for weight loss.

The e-commerce company has beaten its own forecast all year. Is a cheaper stock enough to buy ahead of the next one?

AbbVie also raised its full-year outlook, although the increase was relatively small. Management guided to adjusted EPS in ...

An investment in Anthropic clearly offers investors access to tremendous growth, but risk is high -- so while certain ...

Anduril may be private, but these three publicly traded defense giants could give investors a way to profit from America's ...

By most measures, Rocket Lab (RKLB-7.39%) shares should be well higher. As of July, its backlog stood at $2.36 billion, or ...

Watch hours tell a different story. Netflix did not report growth in viewing hours in the quarter, and viewing hours are ...

Michael Burry hasn't backed off his bet against Palantir Technologies (PLTR-6.27%). When the investor of The Big Short fame ...

Amgen has been posting strong financial results. In the second quarter, the company's revenue increased by 10% year over year ...

A $10,000 investment in SpaceX and Nvidia could rise fivefold by 2030.

In its most recent earnings report, the company forecast an operating margin of 12.5%, though historically that number has ...